investment « Science and Enterprise

In one of its first actions, the Biden administration rejoined the United States in the World Health Organization,… https://t.co/gpHTTr70DP
about 12 hours ago
New post on Science and Enterprise: U.S. Rejoins WHO, Participates in Int’l Vaccine Project https://t.co/bBUZr5UzSg #Science #Business
about 12 hours ago
A clinical trial shows long-term care residents and staff receiving a synthetic antibody treatment have a lower ris… https://t.co/EPYrP8wElE
about 17 hours ago
New post on Science and Enterprise: Antibodies Prevent Covid-19 Symptoms in Long-Term Care https://t.co/sePqojZMVd #Science #Business
about 17 hours ago
Another way to connect 100 million people end-to-end with Covid-19 vaccines. https://t.co/wIWk0XNDhv
about 1 day ago

Crispr Heart Disease Biotech Raises $94M in New Funds

By Alan, on January 19th, 2021%

A company applying Crispr gene-editing technology to treat inherited heart disease is raising $94 million in its second venture funding round. . . . → Read More: Crispr Heart Disease Biotech Raises $94M in New Funds

2020 Venture Funds Mixed, Biotech Keeps Sizzling

By Alan, on January 18th, 2021%

Total venture investments in dollars jumped to a new high in the U.S., while biotechnology remained the single hottest sector in 2020. . . . → Read More: 2020 Venture Funds Mixed, Biotech Keeps Sizzling

Drug Price Disruptor Biotech Raises $500M in New Funds

By Alan, on January 11th, 2021%

A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds

Synthetic Biology Company Raises $105M in New Funds

By Alan, on January 7th, 2021%

A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds

Synthetic Virus Company Forms, Raises $77M

By Alan, on January 5th, 2021%

A new biotechnology enterprise is underway that develops synthetic viruses attacking solid tumor cancers, based on research at the Salk Institute. . . . → Read More: Synthetic Virus Company Forms, Raises $77M

Infographic – Late Charge Boosts Biotech Index

By Alan, on December 26th, 2020%

The Nasdaq Biotechnology Index, an indicator of investor interest in the industry, rose in December to close up by 26 percent for the year. . . . → Read More: Infographic – Late Charge Boosts Biotech Index

Neuroscience Biotech Acquired in $770M Deal

By Alan, on December 17th, 2020%

A three year-old biotechnology company developing treatments for psychiatric and movement disorders is being acquired by global drug maker Novartis. . . . → Read More: Neuroscience Biotech Acquired in $770M Deal

Financial Asset Managers Supporting Net Zero Emissions

By Alan, on December 14th, 2020%

Thirty asset managers, directing investments worth some $9 trillion, agreed to encourage their clients to achieve global net zero greenhouse gas emission goals. . . . → Read More: Financial Asset Managers Supporting Net Zero Emissions

Covid-19 Antibody Developer Raises $483M in IPO

By Alan, on December 11th, 2020%

A biotechnology company developing therapeutic antibodies for Covid-19 infections is raising $483 million in its initial public offering of common stock. . . . → Read More: Covid-19 Antibody Developer Raises $483M in IPO

Start-Up Company Creating Wearable Brain Scanner

By Alan, on December 8th, 2020%

A new enterprise, spun-off from a neuroscience lab in the U.K., is advancing a wearable scanner to detect and diagnose various brain disorders. . . . → Read More: Start-Up Company Creating Wearable Brain Scanner

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise